DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Udwadia ZF, Singh P, Barkate H. et al.
Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial.
Int J Infect Dis 2021;
103: 62-71
DOI: 10.1016/j.ijid.2020.11.142.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.